SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-3 - Registration statement by foreign private issuers:
SEC Accession No. 0001193125-18-016237
Filing Date
2018-01-22
Accepted
2018-01-22 17:25:40
Documents
16

Document Format Files

Seq Description Document Type Size
1 F-3 d517730df3.htm F-3 287530
2 EX-4.1 d517730dex41.htm EX-4.1 3598
3 EX-4.2 d517730dex42.htm EX-4.2 110697
4 EX-4.3 d517730dex43.htm EX-4.3 325858
5 EX-4.4 d517730dex44.htm EX-4.4 271768
6 EX-5.1 d517730dex51.htm EX-5.1 11157
7 EX-23.1 d517730dex231.htm EX-23.1 2679
9 GRAPHIC g517730g0119143618796.jpg GRAPHIC 7137
10 GRAPHIC g517730g0119143618905.jpg GRAPHIC 9903
11 GRAPHIC g517730g11p82.jpg GRAPHIC 17182
12 GRAPHIC g517730g44a32.jpg GRAPHIC 4324
13 GRAPHIC g517730g58r41.jpg GRAPHIC 68137
14 GRAPHIC g517730g88z00.jpg GRAPHIC 3506
15 GRAPHIC g517730pic01.jpg GRAPHIC 493374
16 GRAPHIC g517730pic02.jpg GRAPHIC 95208
17 filename17.htm COVER 5868
  Complete submission text file 0001193125-18-016237.txt   1983832
Mailing Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5
Business Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5 (778) 331-0962
ESSA Pharma Inc. (Filer) CIK: 0001633932 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
Type: F-3 | Act: 33 | File No.: 333-222654 | Film No.: 18540608
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1